Lower volumes are more concentrated and use fewer syringe units
AOD-9604 enhances fat mobilization but cannot overcome consistent caloric surplus
In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
We publish evidence-based guides on HYROX training, peptide therapy, biohacking, and longevity science
AOD-9604 is sometimes discussed alongside BPC-157 in joint research planning, and historically alongside GH secretagogues like Sermorelin, Ipamorelin, and GHRP-6 in fat-loss research planning
By doing so, it helps preserve NAD+ levels, which are crucial for powering your mitochondriathe tiny energy factories inside every cell